Biography
Dr. Xiaohe (Jessie) Jin is a dedicated scientist with a Ph.D. in Chemistry from North Carolina State University and a B.Sc. in Pharmacy from China Pharmaceutical University. Currently serving as Scientist I at Atom Bioworks Inc., Dr. Jin has made significant contributions to the fields of DNA biosensors, drug delivery systems, and biosynthetic pathways of natural products. She has published seven peer-reviewed papers and participated in drafting patents. Fluent in English and Mandarin, Dr. Jin is passionate about advancing scientific research and innovation.
Research Interest
1) Discovery of bioactive gene clusters and compounds from microbes, especially cyanobacteria; (2) Development of DNA nanostructure-based biosensors for diagnostics and drug delivery purposes; and (3) Investigation of the biosynthetic pathways and mechanisms of naturally occurring tetrapyrroles.
Editor
Work Details
Ph.D
North Carolina State University
Department of Chemistry
USA
Contribution by Topic Area
Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
Research Articles
- Kinetic Study of the Removal of Reafix Yellow B8G Dye by Boiler Ash
- Maternal Knowledge and Practices in Caring for Children under Five with Pneumonia: A Cross-Sectional Study in Vietnam
- A Unified Mobility Model for Semiconductor Devices and Sensors, Including Surface Hydrodynamic Viscosity
- Prevalence of Diabetic Retinopathy among Self-reported Newly Diagnosed Diabetics
- Application of Virtual Reality (VR) in Facility Management Competency-based Training (CBT) in the Era of Industrie 5.0
- Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis
Advertisement


